Medpace Holdings Inc (MEDP)
390.13
-9.07
(-2.27%)
USD |
NASDAQ |
May 10, 16:00
390.13
0.00 (0.00%)
After-Hours: 20:00
Medpace Holdings Price to Book Value: 18.00 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 09, 2024 | 18.42 |
May 08, 2024 | 17.88 |
May 07, 2024 | 18.55 |
May 06, 2024 | 18.49 |
May 03, 2024 | 18.11 |
May 02, 2024 | 18.04 |
May 01, 2024 | 18.36 |
April 30, 2024 | 17.92 |
April 29, 2024 | 18.46 |
April 26, 2024 | 18.27 |
April 25, 2024 | 17.98 |
April 24, 2024 | 18.34 |
April 23, 2024 | 18.78 |
April 22, 2024 | 17.36 |
April 19, 2024 | 17.16 |
April 18, 2024 | 17.27 |
April 17, 2024 | 17.64 |
April 16, 2024 | 17.77 |
April 15, 2024 | 17.86 |
April 12, 2024 | 18.22 |
April 11, 2024 | 18.56 |
April 10, 2024 | 18.35 |
April 09, 2024 | 18.68 |
April 08, 2024 | 18.86 |
April 05, 2024 | 18.49 |
Date | Value |
---|---|
April 04, 2024 | 17.96 |
April 03, 2024 | 18.28 |
April 02, 2024 | 18.11 |
April 01, 2024 | 18.36 |
March 31, 2024 | |
March 28, 2024 | 22.40 |
March 27, 2024 | 22.35 |
March 26, 2024 | 22.32 |
March 25, 2024 | 22.30 |
March 22, 2024 | 22.66 |
March 21, 2024 | 22.91 |
March 20, 2024 | 21.96 |
March 19, 2024 | 21.46 |
March 18, 2024 | 21.51 |
March 15, 2024 | 21.83 |
March 14, 2024 | 22.27 |
March 13, 2024 | 22.45 |
March 12, 2024 | 22.43 |
March 11, 2024 | 22.20 |
March 08, 2024 | 22.32 |
March 07, 2024 | 22.54 |
March 06, 2024 | 22.57 |
March 05, 2024 | 22.18 |
March 04, 2024 | 22.14 |
March 01, 2024 | 22.25 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.058
Minimum
Mar 23 2020
22.91
Maximum
Mar 21 2024
10.44
Average
7.490
Median
Jun 22 2022
Price to Book Value Benchmarks
Charles River Laboratories International Inc | 3.254 |
Avid Bioservices Inc | 3.048 |
Iovance Biotherapeutics Inc | 5.241 |
Renovaro Inc | 3.757 |
Candel Therapeutics Inc | 21.46 |
Price to Book Value Related Metrics
PE Ratio | 39.77 |
PS Ratio | 6.320 |
PEG Ratio | 1.645 |
Price to Free Cash Flow | 26.21 |
Price | 390.13 |
Earnings Yield | 2.51% |
Market Cap | 12.09B |
PEGY Ratio | 1.645 |
Operating PE Ratio | 34.97 |
Normalized PE Ratio | 39.77 |